Peripheral Vascular Disease
Peripheral Vascular Disease. Complete a new search. Drug Name (Proprietary . Development Status. Notes. Beraprost SR. none / none. Peripheral Vascular Disease .　->

Modeling Stroke Risk After Coronary Artery Bypass and Combined Coronary .
. models included age, peripheral vascular disease, cardiopulmonary bypass time, . with CAB alone (carotid status unknown) and our population of combined CAB/CEA. .　->

DOI: 10.1161/01.STR.0000069263.08070.9F 2003;34;1212-1217; originally .
consecutive combined CAB/CEA patients operated on between 1994 and 1999 to . included age, aortic calcification, and peripheral vascular disease. .　->

Long-Term Prognosis of Patients With Peripheral Arterial Disease: A .
Survival status of all patients was obtained. . Post-operative and long-term prognosis after vascular surgery is predominantly .　->

Peripheral
. common in their use in both cardiac and peripheral vascular intervention. . for hypertension and coronary artery disease and was status post–stent placement. .　->

Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy .
tory, carotid symptom status, and preprocedural diagnostic . there was a higher incidence of peripheral vascular disease. in the CEA arm (46% vs 38% CAS, P. .　->

Drug Classes Cut Deaths in Peripheral Arterial Disease
data about everything from a post- surgical infection to an unantici . peripheral vascular disease is not placed on a statin. Fur .　->

17 Cerebrovascular Disease and Vascular Access - B?nh H?c
. two definitive trials, current indications for CEA include the following: . assessment for the presence of peripheral vascular disease, diabetes mellitus, .　->

Arch Surg -- Changes in the Use of Carotid Revascularization Among the .
. all patients with a primary diagnostic code for peripheral vascular disease. . (CEA) procedures performed specifically for atherosclerotic disease. .　->